Teva's Levin denies resignation rumors

Jeremy Levin, president and CEO of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), denied rumors that he threatened to resign over disagreements between the company's board and management and said the rumors are "an invention." A Teva spokesperson said the company's management has worked to develop its strategy with "complete cooperation" from the board. Earlier this month, Teva announced a 10% worldwide headcount reduction as part of a plan that will accelerate cost reductions the company first announced in 2012 (see BioCentury Extra, Oct. 10). ...